| The Eye Clinic Pa | |
|
1900 23rd Ave, Gulfport, MS 39501-2965 | |
| (228) 864-2633 | |
| (228) 865-0339 |
| Full Name | The Eye Clinic Pa |
|---|---|
| Type | Facility |
| Speciality | Eyewear Supplier |
| Location | 1900 23rd Ave, Gulfport, Mississippi |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427002864 | NPI | - | NPPES |
| 09013545 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | (* (Not Available)) | Secondary |
| 207W00000X | Ophthalmology | (* (Not Available)) | Secondary |
| 332H00000X | Eyewear Supplier | (* (Not Available)) | Primary |
| Provider Name | Joe R Mitchell |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1508949355 PECOS PAC ID: 1850495243 Enrollment ID: I20070323000362 |
News Archive
During the last three decades, the biopharmaceutical industry has invested significantly in new and improved vaccines, and the collaborative efforts of the [CDC], [the WHO], national governments and industry have led to major progress in addressing global immunization goals and reducing illness and death due to vaccine-preventable diseases.
In the months after separating from military service, most veterans are less satisfied with their health than with their work or social relationships, found a study by Veterans Affairs researchers.
Peregrine Pharmaceuticals, Inc., today announced that noted cancer researcher Bruce Chabner, M.D., will serve as a clinical advisor to the company on the design of clinical trials for the bavituximab cancer program.
Chiron Corporation announced that president and chief executive officer Howard Pien will appear before the U.S. Senate Special Committee on Aging in Washington, D.C., today in a hearing titled, "Combating the Flu: Keeping Seniors Alive."
› Verified 7 days ago
| Provider Name | Roderick D Fields |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1073595906 PECOS PAC ID: 2062572639 Enrollment ID: I20081201000190 |
News Archive
During the last three decades, the biopharmaceutical industry has invested significantly in new and improved vaccines, and the collaborative efforts of the [CDC], [the WHO], national governments and industry have led to major progress in addressing global immunization goals and reducing illness and death due to vaccine-preventable diseases.
In the months after separating from military service, most veterans are less satisfied with their health than with their work or social relationships, found a study by Veterans Affairs researchers.
Peregrine Pharmaceuticals, Inc., today announced that noted cancer researcher Bruce Chabner, M.D., will serve as a clinical advisor to the company on the design of clinical trials for the bavituximab cancer program.
Chiron Corporation announced that president and chief executive officer Howard Pien will appear before the U.S. Senate Special Committee on Aging in Washington, D.C., today in a hearing titled, "Combating the Flu: Keeping Seniors Alive."
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| The Eye Clinic Pa Po Box 148, Gulfport, MS 39502-0148 Ph: (228) 864-2633 | The Eye Clinic Pa 1900 23rd Ave, Gulfport, MS 39501-2965 Ph: (228) 864-2633 |
News Archive
During the last three decades, the biopharmaceutical industry has invested significantly in new and improved vaccines, and the collaborative efforts of the [CDC], [the WHO], national governments and industry have led to major progress in addressing global immunization goals and reducing illness and death due to vaccine-preventable diseases.
In the months after separating from military service, most veterans are less satisfied with their health than with their work or social relationships, found a study by Veterans Affairs researchers.
Peregrine Pharmaceuticals, Inc., today announced that noted cancer researcher Bruce Chabner, M.D., will serve as a clinical advisor to the company on the design of clinical trials for the bavituximab cancer program.
Chiron Corporation announced that president and chief executive officer Howard Pien will appear before the U.S. Senate Special Committee on Aging in Washington, D.C., today in a hearing titled, "Combating the Flu: Keeping Seniors Alive."
› Verified 7 days ago